Fipronil induces CYP isoforms and cytotoxicity in human hepatocytes

Parikshit C Das1, Yan Cao, Nathan Cherrington

  • 1Department of Environmental and Molecular Toxicology, North Carolina State University, Raleigh, NC 27695-7633, USA.

Insights

Fipronil pesticide exposure significantly increases human CYP1A1 and CYP3A4 enzyme expression, but can also cause cytotoxic and apoptotic effects in liver cells. Further research is needed to understand fipronil

Area of Science:

  • Toxicology
  • Enzymology
  • Cell Biology

Background:

  • Pesticides can modulate human xenobiotic metabolizing enzymes.
  • Fipronil is a widely used insecticide with potential human health implications.

Purpose of the Study:

  • To investigate the effects of fipronil on xenobiotic metabolizing enzymes in human hepatocytes.
  • To assess the cytotoxic effects of fipronil and its metabolite, fipronil sulfone, in liver cells.

Main Methods:

  • Human hepatocytes and HepG2 cells were exposed to varying doses of fipronil.
  • Enzyme expression and activity were measured using branched DNA assays, Western blotting, and enzyme activity assays.
  • Cytotoxicity was assessed using adenylate kinase and trypan blue exclusion assays.
  • Apoptosis was evaluated by measuring caspase-3/7 activity.

Main Results:

  • Fipronil dose-dependently induced CYP1A1, CYP3A4, CYP2B6, and CYP3A5 mRNA expression.
  • Enzyme activity assays confirmed increased CYP1A1 and CYP3A4 activity at lower fipronil concentrations, with decreased activity at higher doses.
  • Fipronil and fipronil sulfone exhibited cytotoxic effects in both HepG2 cells and primary human hepatocytes.
  • Apoptosis was indicated by the induction of caspase-3/7 activity.

Conclusions:

  • Fipronil can induce key drug-metabolizing enzymes in human liver cells, potentially altering drug metabolism.
  • Fipronil and its metabolite demonstrate significant cytotoxicity and induce apoptosis in hepatocytes.
  • The findings highlight the need for further investigation into the toxicological risks associated with fipronil exposure.

Related Concept Videos

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes01:28

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes

Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450 isoenzymes,...
Bioactivation and Tissue Toxicity01:25

Bioactivation and Tissue Toxicity

Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...